Citigroup Cuts Astera Labs (NASDAQ:ALAB) Price Target to $250.00

Astera Labs (NASDAQ:ALAB) had its price objective lowered by Citigroup from $275.00 to $250.00 in a research report sent to investors on Wednesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock.

Several other research firms also recently weighed in on ALAB. Barclays set a $165.00 price target on shares of Astera Labs in a research note on Thursday, January 15th. Stifel Nicolaus lifted their target price on Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Morgan Stanley reiterated an “overweight” rating and issued a $210.00 target price on shares of Astera Labs in a report on Wednesday, December 3rd. Weiss Ratings reissued a “hold (c-)” rating on shares of Astera Labs in a research report on Wednesday, January 21st. Finally, Wall Street Zen downgraded Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Fourteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $192.89.

Astera Labs Trading Up 2.2%

Shares of ALAB opened at $129.32 on Wednesday. The firm has a fifty day moving average price of $164.09 and a 200-day moving average price of $174.12. The firm has a market capitalization of $21.84 billion, a P/E ratio of 106.00, a P/E/G ratio of 2.74 and a beta of 1.50. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The firm’s revenue for the quarter was up 91.8% on a year-over-year basis. During the same quarter last year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts predict that Astera Labs will post 0.34 earnings per share for the current year.

Insiders Place Their Bets

In other Astera Labs news, CFO Michael Truett Tate sold 11,430 shares of Astera Labs stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the transaction, the chief financial officer owned 192,297 shares in the company, valued at $27,823,452.93. The trade was a 5.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Manuel Alba sold 150,000 shares of the business’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. This represents a 8.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 576,936 shares of company stock worth $87,409,540. Insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. Assetmark Inc. lifted its position in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in shares of Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Hilltop National Bank lifted its holdings in shares of Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the last quarter. Aventura Private Wealth LLC acquired a new stake in shares of Astera Labs in the 4th quarter worth $33,000. Finally, National Bank of Canada FI grew its stake in Astera Labs by 159.0% during the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after buying an additional 124 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q4 results beat consensus (revenue and EPS ahead) and management gave solid Q1 guidance, supporting the growth narrative tied to AI/hyperscaler demand. ALAB Stock Dips 31% Post Q4 Earnings
• Positive Sentiment: Northland Securities reiterated an Outperform rating and published multi-quarter EPS projections plus a $195 price target — a bullish analyst signal that supports upside if execution continues. MarketBeat – Northland Estimates
• Neutral Sentiment: Several deep-dive writeups and the Q4 earnings transcript are available for investors parsing the details (growth, product cadence, Scorpio X timing). These are useful for assessing whether margin pressures are one-off or structural. Earnings Call Transcript
• Neutral Sentiment: Short-interest reports in the feed show anomalous “0 shares / NaN” values across dates — data appears erroneous and provides no reliable signal on short pressure. (Treat short-interest figures cautiously.)
• Negative Sentiment: Investors sold aggressively after management flagged margin headwinds and rising operating expenses; multiple outlets report a sharp post-earnings drop as traders re-priced the stock despite the beat. ALAB Stock Slides
• Negative Sentiment: Analyst downgrade / notes and reports of a gap-down move amplified the sell-off — negative research and headlines can pressure sentiment even when fundamentals look strong. Shares Gap Down Following Analyst Downgrade
• Negative Sentiment: Coverage pieces explain the paradox: stellar revenue growth but margin guidance and near-term opex make the print look less clean, prompting profit-taking and volatility. Why Stock Crashed Despite Strong Earnings

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.